These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
280 related items for PubMed ID: 1327513
1. Sensitivity to novel platinum compounds of panels of human lung cancer cell lines with acquired and inherent resistance to cisplatin. Twentyman PR, Wright KA, Mistry P, Kelland LR, Murrer BA. Cancer Res; 1992 Oct 15; 52(20):5674-80. PubMed ID: 1327513 [Abstract] [Full Text] [Related]
3. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. Kasahara K, Fujiwara Y, Nishio K, Ohmori T, Sugimoto Y, Komiya K, Matsuda T, Saijo N. Cancer Res; 1991 Jun 15; 51(12):3237-42. PubMed ID: 1645616 [Abstract] [Full Text] [Related]
4. Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells. Stordal BK, Davey MW, Davey RA. Cancer Chemother Pharmacol; 2006 Aug 15; 58(2):256-65. PubMed ID: 16283310 [Abstract] [Full Text] [Related]
9. Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines. Yoshida M, Khokhar AR, Siddik ZH. Cancer Res; 1994 Jul 01; 54(13):3468-73. PubMed ID: 8012968 [Abstract] [Full Text] [Related]
10. Comparison of cellular accumulation and cytotoxicity of cisplatin with that of tetraplatin and amminedibutyratodichloro(cyclohexylamine)platinum(IV) (JM221) in human ovarian carcinoma cell lines. Mistry P, Kelland LR, Loh SY, Abel G, Murrer BA, Harrap KR. Cancer Res; 1992 Nov 15; 52(22):6188-93. PubMed ID: 1423261 [Abstract] [Full Text] [Related]
11. A study of ethacrynic acid as a potential modifier of melphalan and cisplatin sensitivity in human lung cancer parental and drug-resistant cell lines. Rhodes T, Twentyman PR. Br J Cancer; 1992 May 15; 65(5):684-90. PubMed ID: 1316774 [Abstract] [Full Text] [Related]
12. Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates. Kelland LR, Mistry P, Abel G, Loh SY, O'Neill CF, Murrer BA, Harrap KR. Cancer Res; 1992 Jul 15; 52(14):3857-64. PubMed ID: 1617660 [Abstract] [Full Text] [Related]
13. Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Behrens BC, Hamilton TC, Masuda H, Grotzinger KR, Whang-Peng J, Louie KG, Knutsen T, McKoy WM, Young RC, Ozols RF. Cancer Res; 1987 Jan 15; 47(2):414-8. PubMed ID: 3539322 [Abstract] [Full Text] [Related]
14. In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin. Mellish KJ, Kelland LR, Harrap KR. Br J Cancer; 1993 Aug 15; 68(2):240-50. PubMed ID: 8347478 [Abstract] [Full Text] [Related]
17. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance. Sharp SY, Rogers PM, Kelland LR. Clin Cancer Res; 1995 Sep 15; 1(9):981-9. PubMed ID: 9816070 [Abstract] [Full Text] [Related]